Blastic Plasmacytoid Dendritic Cell Neoplasm: Report of a Case with Atypical Cytology and Immunophenotype
Journal: Journal of Blood Disorders (Vol.2, No. 3)Publication Date: 2015-08-14
Authors : Lamar E; Roggy A; Le Calvez G; Marion V; Buors C; Quintin-Roue I; Costa S; Morel F; Brenaut E; Tempescul A; Biichle S; Garnache- Ottou F; Ugo V;
Page : 1-3
Keywords : Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN); Leukemia; Plasmacytoid dendritic cell; Diagnosis; Immunophenotyping;
Abstract
Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN) or Plasmacytoid Dendritic Cell Leukemia (pDCL) is a rare and aggressive malignancy, whose diagnosis is mainly based on phenotypic characterization of the blastic cells with CD4+/CD56+ antigens. We report a BPDCN case with a blastic population expressing CD4 with no CD56 expression. In cytology, the classical “pearl necklace” aspect was missing. The diagnosis was made thanks to the specific BPDCN markers, namely CD303 (BDCA2), CD304 (BDCA4), and cTCL1. Biologists should be aware of this atypical presentation.
Other Latest Articles
- DNMT3A Mutations in Tunisian Patients with Acute Myeloid Leukemia
- Involvement of Dock8 in a Paracentric Inversion Affecting the Derivative Chromosome 9 in a Case of Philadelphia Positive Chronic Myeloid Leukemia
- Implications of TP53 Gene Mutations in Myelodysplastic Syndromes: A Review
- Haemorrheological Changes in Malaria Infected Pregnant Subject Attending Antenatal Clinic at Eku Baptist Government Hospital
- Pseudotumors of the Limbs in Patients with Hemophilia
Last modified: 2016-10-21 16:14:37